Challenges, Progress, and Opportunities: Proceedings of the Filovirus Medical Countermeasures Workshop

被引：27

作者：

Hirschberg, Rona ^{[1
]}

Ward, Lucy A. ^{[1
]}

Kilgore, Nicole ^{[2
]}

Kurnat, Rebecca ^{[2
]}

Schiltz, Helen ^{[1
]}

Albrecht, Mark T. ^{[3
]}

Christopher, George W. ^{[4
]}

Nuzum, Ed ^{[1
]}

机构：

[1] NIAID, Div Microbiol & Infect Dis, NIH, Bethesda, MD 20892 USA

[2] Med Countermeasure Syst, Dept Def, Frederick, MD 21702 USA

[3] Biodefense Adv Res & Dev Author, Assistant Secretary Preparedness & Response, Dept Hlth & Human Serv, Washington, DC 20201 USA

[4] Dept Def, Med Countermeasure Syst, Ft Belvoir, VA 22060 USA

来源：

VIRUSES-BASEL | 2014年 / 6卷 / 07期

关键词：

Ebola; Sudan; ebolavirus; Marburg virus; marburgvirus; Filoviridae; filovirus medical countermeasures; Filovirus Animal Non-clinical Group; FANG; HIV-1 ENV VACCINE; EBOLA-VIRUS; NONHUMAN-PRIMATES; ADENOVIRUS; PROTECTION; INFECTION; IMMUNOGENICITY; RESPONSES;

D O I：

10.3390/v6072673

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

On August 22-23, 2013, agencies within the United States Department of Defense (DoD) and the Department of Health and Human Services (HHS) sponsored the Filovirus Medical Countermeasures (MCMs) Workshop as an extension of the activities of the Filovirus Animal Non-clinical Group (FANG). The FANG is a federally-recognized multi-Agency group established in 2011 to coordinate and facilitate U. S. government (USG) efforts to develop filovirus MCMs. The workshop brought together government, academic and industry experts to consider the needs for filovirus MCMs and evaluate the status of the product development pipeline. This report summarizes speaker presentations and highlights progress and challenges remaining in the field.

引用

页码：2673 / 2697

页数：25

共 50 条

[21] Progress, Challenges and Opportunities of Electromobility in Mexico
Salgado-Conrado, Lizbeth
Alvarez-Macias, Carlos
Loera-Palomo, Rodrigo
Garcia-Contreras, C. Pamela
[J]. SUSTAINABILITY, 2024, 16 (09)
[22] Neuroscience nanotechnology: Progress, opportunities and challenges
Silva, GA
[J]. NATURE REVIEWS NEUROSCIENCE, 2006, 7 (01) : 65 - 74
[23] Delivering the promise: Progress, challenges, opportunities
Jones, Daniel W.
[J]. HYPERTENSION, 2008, 51 (06) : 1399 - 1402
[24] The nanostructure problem: challenges, progress, opportunities
Billinge, Simon
[J]. ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2017, 73 : C31 - C31
[25] NO direct decomposition: progress, challenges and opportunities
Xie, Pingping
Ji, Wenxue
Li, Yongdan
Zhang, Cuijuan
[J]. CATALYSIS SCIENCE & TECHNOLOGY, 2021, 11 (02) : 374 - 391
[26] Solar thermophotovoltaics: Progress, challenges, and opportunities
Wang, Yang
Liu, Haizhou
Zhu, Jia
[J]. APL MATERIALS, 2019, 7 (08):
[27] Progress of ATM inhibitors: Opportunities and challenges
Du, Shan
Liang, Qi
Shi, Jianyou
[J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 277
[28] Cancer nanomedicine: progress, challenges and opportunities
Jinjun Shi
Philip W. Kantoff
Richard Wooster
Omid C. Farokhzad
[J]. Nature Reviews Cancer, 2017, 17 : 20 - 37
[29] WTO Accession Brings Opportunities, Challenges to CNOOC and Corresponding Countermeasures
Huang Xin
Lai Nanjun
[J]. MATERIALS SCIENCE AND INFORMATION TECHNOLOGY, PTS 1-8, 2012, 433-440 : 1492 - +
[30] NNI Workshop Charts Progress and Future Challenges
Jennifer Ouelette
[J]. MRS Bulletin, 2002, 27 (7) : 495 - 495

← 1 2 3 4 5 →